Literature DB >> 2187809

Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection.

H C Polk1, P M Lamont, R B Galland.   

Abstract

Observations made during the study of nonspecific enhancement of antimicrobial host defenses permitted some physiologic dissection of the anatomic basis for normal protective processes. Local growth of bacteria in the hind limb in muramyl dipeptide-treated mice was suppressed modestly, but lymphatic filtration was markedly improved, especially between the ipsilateral groin and iliac lymph nodes. Spontaneous containment, when it occurred in saline-treated controls, proceeded similarly. Certain regional lymph nodes acted to restrict the dissemination of bacteria from an anatomically isolated infection, reducing the degree of bacteremia and improving survival. Containment of local bacterial infection appears more important in a favorable host response than does dispersion and is accentuated by muramyl dipeptide.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187809      PMCID: PMC258727          DOI: 10.1128/iai.58.6.1807-1811.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  The influence of the route of injection on lethal infections in mice.

Authors:  A A DUTTON
Journal:  Br J Exp Pathol       Date:  1955-04

Review 2.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.

Authors:  L Chedid; F Audibert; A G Johnson
Journal:  Prog Allergy       Date:  1978

3.  Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.

Authors:  I Löwy; C Bona; L Chedid
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

Review 4.  Birth-death and other models for microbial infection.

Authors:  P Armitage; G G Meynell; T Williams
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

5.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.

Authors:  M Fevrier; J L Birrien; C Leclerc; L Chedid; P Liacopoulos
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

7.  Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.

Authors:  N P Cummings; M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  Corynebacterium parvum: immunomodulation in local bacterial infections.

Authors:  K Calhoun; L Trachtenberg; K Hart; H C Polk
Journal:  Surgery       Date:  1980-01       Impact factor: 3.982

9.  Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice.

Authors:  J R Ausobsky; W G Cheadle; B G Brosky; H C Polk
Journal:  Br J Surg       Date:  1984-02       Impact factor: 6.939

10.  Nonspecific enhancement of resistance to bacterial infection: evidence of an effect supplemental to antibiotics.

Authors:  H C Polk; R B Galland; J R Ausobsky
Journal:  Ann Surg       Date:  1982-10       Impact factor: 12.969

View more
  4 in total

1.  Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms.

Authors:  J Franĕk; J Malina; H Krátká
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

2.  Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide in treatment of experimental Klebsiella pneumoniae infection.

Authors:  P M Melissen; W van Vianen; Y Rijsbergen; I A Bakker-Woudenberg
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

3.  Roles of peripheral leukocytes and tissue macrophages in antibacterial resistance induced by free or liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.

Authors:  P M Melissen; W van Vianen; I A Bakker-Woudenberg
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

4.  Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.

Authors:  P M Melissen; W van Vianen; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.